Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-09-25A Phase 2, Multicenter, Double-Blind, Placebo-Controlled Comparator Study of 2 Doses of LY2140023 Versus Placebo in Patients With DSM-IV-TR Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-09-19Using a Visual Decision Aid (DA) to Facilitate Shared Decision Making (SDM) During Antipsychotic Treatment in Schizophrenia.
-
CLINICAL_TRIALS study record update · 2012-09-18An Open-Label, Positron Emission Tomography (PET) Study to Evaluate the Brain 5 HT6 Receptor Occupancy by Single Doses of SLV354 in Healthy Male Subjects and Subjects With Stable Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-09-18The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center
-
CLINICAL_TRIALS study record update · 2012-09-18The Effects of Glycine Transport Inhibition on Brain Glycine Concentration
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-09-17IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder
-
CLINICAL_TRIALS study record update · 2012-09-17ClinicalTrials.gov study NCT00629252
-
CLINICAL_TRIALS study record update · 2012-09-13Phase IV Study of Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-09-13Aripiprazole for Clozapine Associated Medical Morbidity
-
CLINICAL_TRIALS study record update · 2012-09-12Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia: a Randomized, Controlled, Double Blind, Two-armed Clinical Trial
-
CLINICAL_TRIALS study record update · 2012-09-10A Long-Term Study of JNS007ER in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-09-07A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
-
CLINICAL_TRIALS study record update · 2012-08-31A Multi-Center, Open-Label, Safety and Tolerability Study of Flexible-Dose Oral Aripiprazole (2 Mg-30 mg) in the Treatment of Adolescent Patients With Schizophrenia and Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
-
CLINICAL_TRIALS study record update · 2012-08-29The Paliperidone ER Outcomes Study of Schizophrenia Patients in Typical Clinical Practice
-
CLINICAL_TRIALS study record update · 2012-08-27Open Label, Non-randomised, Single Arm, Phase IIIB Switch Study: Evaluating the Clinical Benefits of Quetiapine XR in Patients With Schizophrenia and Anxiety Disorder.
-
CLINICAL_TRIALS study record update · 2012-08-22ClinicalTrials.gov study NCT00631722
-
CLINICAL_TRIALS study record update · 2012-08-16A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
-
CLINICAL_TRIALS study record update · 2012-08-14Meaningful Change With the Method Guided Self-Determination - a Randomised Controlled Study for Patients Diagnosed With Schizophrenia.
-
CLINICAL_TRIALS study record update · 2012-08-08Family Intervention for SMI and Substance Use Disorder
-
CLINICAL_TRIALS study record update · 2012-08-06A Comparison of Risperidone and Haloperidol for Prevention of Relapse in Subjects With Schizophrenia and Schizoaffective Disorders
-
CLINICAL_TRIALS study record update · 2012-08-01Aripiprazole in Adolescents With Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-07-30CARE II - Evaluation of Treatment Outcomes in Schizophrenic Patients Taking Part in the Integrated Care Program - a Single-country, Multi-centre Phase IV Study
-
CLINICAL_TRIALS study record update · 2012-07-27A 24-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil (150, 200, and 250 mg/ Day) as Adjunctive Therapy in Adults With Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-07-27A Phase IV Prospective, Double-blind, Double-dummy, Randomised, Crossover Study to Assess the Impact on Daily Cognitive Functioning of Quetiapine Fumarate Immediate Release (Seroquel IR®) Dosed Twice Daily and Quetiapine Fumarate Extended Release (Seroquel XR®) Dosed Once Daily in the Evening in Patients With Stable Schizophrenia
-
CLINICAL_TRIALS study record update · 2012-07-26Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia: a 6-week, Randomized, Double-blind Placebo-controlled Trial